US2022015342A1PendingUtilityA1
Gene editing of reproductive hormones to reduce fertility in ictalurus punctatus
Est. expiryJun 3, 2036(~9.9 yrs left)· nominal 20-yr term from priority
A01K 2217/075C12N 15/8509A01K 67/0276C07K 14/461C12N 9/22A01K 2267/02A01K 2227/40C12N 15/90A01K 2217/00C12N 15/102C12N 9/222
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed are fish with impaired reproductive capacity and methods and compositions for producing the same. The reproductively impaired fish may include catfish, such as Ictalurus punctatus . The disclosed methods may be generally useful for mitigating environmental impact of escaped genetically engineered fish.
Claims
exact text as granted — not AI-modified1 . A method for reducing fertility in a fish comprising modifying the DNA sequence of said fish's luteinizing hormone, gonadotropin-releasing hormone, or follicle-stimulating hormone gene.
2 . The method of claim 1 wherein the DNA sequence is modified using at least one DNA nuclease.
3 . The method of claim 2 wherein the DNA nucleases are a zinc finger nuclease, a TALEN nuclease, a CRISPR nuclease, or a combination of zinc finger nucleases, TALEN nucleases, or CRISPR nucleases.
4 . The method of claim 1 wherein the modification to said fish's DNA¬¬ comprises deletions, insertions, base changes, or combinations of any one of these in the DNA sequence.
5 . A method for inducing modifications to a nucleic acid sequence in a living cell comprising electroporating at least two times to deliver at least one plasmid encoding at least one DNA nuclease.
6 . The method of claim 5 wherein at least one DNA nuclease is a zinc finger nuclease, a TALEN nuclease, a CRISPR nuclease, or a combination of zinc finger nucleases, TALEN nucleases, or CRISPR nucleases.
7 . The method of claim 6 wherein the DNA nuclease binds to a nucleic acid sequence that is at least 80% similar to SEQ ID NOs:1, 2, 3, 12, 13, 14, 15, or 16.
8 . The method of claim 5 wherein the modification to the DNA comprises base changes, deletions or insertions in the sequence of said living cell, wherein the DNA comprises the luteinizing hormone, gonadotropin-releasing hormone, or follicle-stimulating hormone gene.
9 . A fish with a modified luteinizing hormone, gonadotropin-releasing hormone, or follicle-stimulating hormone gene such that functional luteinizing hormone, Gonadotropin-releasing hormone, or follicle-stimulating hormone gene product is no longer produced.
10 . The fish of claim 9 wherein modifications to the fish's luteinizing hormone, gonadotropin-releasing hormone, or follicle-stimulating hormone genes comprise deletions, insertions, base changes, or combinations of any one of these in the native gene sequence.
11 . The fish of claim 10 wherein the deletions or insertions are in or near nucleic acid sequences with at least 80% similar to SEQ ID NOs:1, 2, 3, 12, 13, 14, 15, or 16.
12 . A DNA vector encoding at least one DNA nuclease that binds to the catfish luteinizing hormone, gonadotropin-releasing hormone, or follicle-stimulating hormone gene sequence.
13 . The vector of claim 12 wherein the at least one DNA, nuclease is comprised of a zinc finger nuclease, a TALEN nuclease, or a CRISPR nuclease.
14 . The vector of claim 12 wherein the DNA nuclease binds to a nucleic acid sequence that is at least 80% similar to SEQ ID NOs:1, 2, 3, 12, 13, 14, 15, or 16.Join the waitlist — get patent alerts
Track US2022015342A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.